Legis Daily

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

USA118th CongressS-1852| Senate 
| Updated: 9/6/2023
Tim Scott

Tim Scott

Republican Senator

South Carolina

Cosponsors (2)
Cory A. Booker (Democratic)Raphael G. Warnock (Democratic)

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 115-2465
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Jun 7, 2023
Introduced in Senate
Jun 7, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 15, 2023
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Sep 6, 2023
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
Sep 6, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
Sep 24, 2024

Latest Companion Bill Action

HR 118-3884
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    S 115-2465
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018


  • June 7, 2023
    Introduced in Senate


  • June 7, 2023
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • June 15, 2023
    Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.


  • September 6, 2023
    Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.


  • September 6, 2023
    Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.


  • September 24, 2024

    Latest Companion Bill Action

    HR 118-3884
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

USA118th CongressS-1852| Senate 
| Updated: 9/6/2023
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 115-2465
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Jun 7, 2023
Introduced in Senate
Jun 7, 2023
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jun 15, 2023
Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.
Sep 6, 2023
Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.
Sep 6, 2023
Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.
Sep 24, 2024

Latest Companion Bill Action

HR 118-3884
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • Bill from Previous Congress

    S 115-2465
    Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018


  • June 7, 2023
    Introduced in Senate


  • June 7, 2023
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.


  • June 15, 2023
    Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.


  • September 6, 2023
    Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.


  • September 6, 2023
    Placed on Senate Legislative Calendar under General Orders. Calendar No. 201.


  • September 24, 2024

    Latest Companion Bill Action

    HR 118-3884
    Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Tim Scott

Tim Scott

Republican Senator

South Carolina

Cosponsors (2)
Cory A. Booker (Democratic)Raphael G. Warnock (Democratic)

Health, Education, Labor, and Pensions Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Blood and blood diseasesGeneticsHealth promotion and preventive careHereditary and development disordersMedical researchResearch administration and funding